About the Event
InSitu Biologics is a clinical stage pharmaceutical company with a disruptive drug delivery platform that increases safety and performance of treatments thanks to precision local delivery and proprietary controlled-release technology.
The first target of this technology is post-operative pain management due to the enormous size of the market and the huge benefit it will provide to society. Just one peripheral nerve block injection using InSitu’s technology provides 5 days of pain management with NO OPIOIDS! This extended relief platform offers new hope to the 100 million surgical patients whose only other option to manage pain is opioids.
Join our fireside chat to get a physician’s perspective on pain management and the effect on patients when they are introduced to opioids featuring:
• Dr. Matthew Purcell: Staff anesthesiologist at SSM St Agnes Hospital and clinical advisor to InSitu
• Dr. Mark Ereth: Emeritus Professor at Mayo Clinic College of Medicine and Chief Medical Officer of InSitu
• Kevin Bassett: InSitu President and CEO
Doctors Purcell and Ereth will also talk about why they have chosen to invest in InSitu.